R. Uthe

BRCA 1/2 gene mutation and gastrointestinal stromal tumours: a potential association

K. Siziopikou, V. Kaklamani, Julie Waisbren, 2015, BMJ Case Reports.

Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579)

N. Hansen, W. Gradishar, A. Gutin, 2015, Breast Cancer Research and Treatment.

Durvalumab and tremelimumab in metastatic breast cancer (MBC): Immunotherapy and immunopharmacogenomic dynamics.

Yusuke Nakamura, W. Gradishar, Jae-Hyun Park, 2017 .

A prospective evaluation of clinical and genetic predictors of weight changes in breast cancer survivors

C. Mantzoros, D. Ankerst, Katharina Selig, 2017, Cancer.

Pilot neoadjuvant trial in HER2 positive breast cancer with combination of nab-paclitaxel and lapatinib

N. Hansen, D. Scholtens, W. Gradishar, 2012, Breast Cancer Research and Treatment.

A pilot study of durvalumab and tremelimumab and immunogenomic dynamics in metastatic breast cancer

A. Rademaker, Yusuke Nakamura, W. Gradishar, 2018, Oncotarget.

A Phase I Trial of a Pegylated Liposomal Anthracycline (DoxilTM) and Lapatinib Combination in the Treatment of Metastatic Breast Cancer: Dose-Escalation Results of an Anthracycline and Lapatinib Combination Trial.

A. Rademaker, W. Gradishar, S. Rubin, 2009 .